Exercise performance in hypertrophic cardiomyopathies

European Heart Journal
|November 1, 1983
PubMed

Insights

Exercise testing reveals impaired stroke volume and elevated pulmonary artery pressure in hypertrophic cardiomyopathy patients. Medical and surgical treatments improve exercise capacity, with surgery being most effective.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Hemodynamics

Background:

  • Hypertrophic cardiomyopathy (HCM) encompasses obstructive (HOCM) and non-obstructive (HNCM) forms, affecting cardiac function.
  • Understanding exercise-induced hemodynamic changes is crucial for assessing functional impairment in HCM patients.

Purpose of the Study:

  • To evaluate hemodynamic parameters during exercise in HOCM and HNCM patients.
  • To compare the efficacy of propranolol, verapamil, and surgical treatment on exercise capacity and hemodynamics in HOCM.

Main Methods:

  • Bicycle ergometer tests were performed on 69 patients (50 HOCM, 19 HNCM) across NYHA classes I-IV.
  • Hemodynamic parameters including heart rate, stroke volume index, cardiac index, and pulmonary artery pressure were measured.
  • Clinical and hemodynamic outcomes of propranolol, verapamil, and surgical treatment were compared in 53 HOCM patients.

Main Results:

  • Increasing clinical severity correlated with decreased stroke volume and increased pulmonary artery pressure.
  • Abnormal stroke volume response to exercise occurred in 48% of HOCM and 26% of HNCM patients.
  • Verapamil and surgery significantly improved maximal exercise capacity compared to propranolol, with surgery showing the greatest benefit.

Conclusions:

  • Exercise hemodynamics are essential for defining functional impairment in individual HCM patients.
  • Verapamil and surgical treatment offer superior improvements in exercise capacity and hemodynamics over propranolol.
  • Surgical treatment demonstrates the most significant positive impact on maximal exercise capacity in HOCM.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...